Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 1 | Respiratory Research

Fig. 1

From: Targeting of nicotinamide phosphoribosyltransferase enzymatic activity ameliorates lung damage induced by ischemia/reperfusion in rats

Fig. 1

Effect of FK866 on pulmonary edema. Lung weight gain (a), Kf (b), lung wet/dry (W/D) weight ratios (c), lung weight/body weight (LW/BW) ratios (d), and protein concentrations in the bronchoalveolar lavage fluid (BALF) (e) significantly increased in the ischemia-reperfusion (IR) group. Treatment with FK866 significantly attenuated the increase in these parameters. Data are expressed as mean ± SD (n = 6 per group). ***p < 0.001, compared with the control group; +++ p < 0.001, compared with the IR group

Back to article page